China Universal Asset Management Co., Ltd. Arcellx, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 10,177 shares of ACLX stock, worth $556,885. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,177
Previous 10,177
-0.0%
Holding current value
$556,885
Previous $708,000
0.14%
% of portfolio
0.09%
Previous 0.09%
Shares
11 transactions
Others Institutions Holding ACLX
# of Institutions
186Shares Held
43.4MCall Options Held
73.8KPut Options Held
196K-
Perceptive Advisors LLC New York, NY3.93MShares$215 Million5.74% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.82MShares$209 Million9.96% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$205 Million18.28% of portfolio
-
Black Rock Inc. New York, NY3.07MShares$168 Million0.01% of portfolio
-
Sr One Capital Management, LP2.35MShares$128 Million54.95% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.4B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...